Lypro Biosciences Inc.
Berkeley, CA
Lypro BioSciences is a specialty biopharma company whose technology addresses the adverse effects arising from the insoluble nature of certain hydrophobic drugs – drugs that are poorly soluble in the blood stream. Lypro's technology is based on self-assembling, targetable, nanometer-scale bioparticles termed "NanoDisk". Incorporating hydrophobic bioactive agents into the stable and water-soluble NanoDisk holds the promise of increased efficacy, lower doses, and reduced incidence and severity of side effects compared to current formulations.